Lucid Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5.45	4.71	4.35	2.43	0.38	0.5
Revenue Growth	24.88%	8.28%	79.00%	544.03%	-24.60%	-
Cost of Revenue	6.63	6.67	7.1	5.98	3.61	0.59
Gross Profit	-1.18	-1.96	-2.75	-3.55	-3.24	-0.09
Selling, General & Admin	43.69	41.58	36.62	35.66	40.11	18.04
Research & Development	5.39	5.68	5.99	7.25	11.26	9.3
Amortization of Goodwill & Intangibles	0.42	0.42	0.69	2.02	1.65	-
Operating Expenses	49.5	47.68	43.3	44.93	53.01	27.33
Operating Income	-50.68	-49.64	-46.05	-48.48	-56.25	-27.42
Interest Expense	-0.02	-0.02	-0.03	-0.42	-0.01	-0.66
Interest & Investment Income	0.36	0.39	0.32	0.42	0.09	-
Other Non Operating Income (Expenses)	-	-	-	-1.19	-	-
EBT Excluding Unusual Items	-50.34	-49.28	-45.76	-49.66	-56.17	-28.08
Other Unusual Items	-1.92	-8.73	0.23	-3.01	-	-
Pretax Income	-52.26	-58.01	-45.53	-52.67	-56.17	-28.08
Net Income	-52.26	-58.01	-45.53	-52.67	-56.17	-28.08
Preferred Dividends & Other Adjustments	12.75	12.56	7.5	-	-	-
Net Income to Common	-65.01	-70.57	-53.03	-52.67	-56.17	-28.08
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	141	102	51	42	36	19
Shares Outstanding (Diluted)	141	102	51	42	36	19
Shares Change	103.51%	101.81%	20.98%	15.44%	94.44%	31.81%
EPS (Basic)	-0.46	-0.69	-1.05	-1.26	-1.55	-1.51
EPS (Diluted)	-0.46	-0.69	-1.05	-1.26	-1.55	-1.51
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-47.18	-46.68	-44.44	-33.04	-30.59	-18.53
Free Cash Flow Per Share	-0.34	-0.46	-0.88	-0.79	-0.85	-1.00
Gross Margin	-21.69%	-41.73%	-63.35%	-146.25%	-	-17.00%
Operating Margin	-930.82%	-1054.82%	-1059.64%	-1996.79%	-14920.69%	-5483.80%
Profit Margin	-1193.87%	-1499.55%	-1220.09%	-2169.11%	-14899.47%	-5615.60%
Free Cash Flow Margin	-866.56%	-991.97%	-1022.46%	-1360.71%	-8114.85%	-3706.00%
EBITDA	-49.81	-48.77	-44.89	-45.98	-54.32	-27.42
D&A For EBITDA	0.88	0.87	1.17	2.5	1.94	0
EBIT	-50.68	-49.64	-46.05	-48.48	-56.25	-27.42

SEC Filings: 10-K · 10-Q